InvestorsHub Logo
Followers 1
Posts 232
Boards Moderated 0
Alias Born 01/23/2014

Re: f3tt3f post# 4392

Thursday, 02/13/2014 12:14:13 AM

Thursday, February 13, 2014 12:14:13 AM

Post# of 703844

If pre-defined in the trial design, FDA might be more likely to consider it as a potential subset for post hoc analysis approval (if necessary).



I wonder if that's what this "extension" is about.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News